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Abstract 26 
The gut microbiota is increasingly implicated in the pathogenesis of Crohn’s disease (CD) 27 
and ulcerative colitis (UC) although the identity of the bacteria that underpin these diseases 28 
has remained elusive.  The pathobiont Bacteroides vulgatus has been associated with both 29 
diseases although relatively little is known about how its growth and functional activity might 30 
drive the host inflammatory response.  We identified an ATP Binding Cassette (ABC) export 31 
system and lipoprotein in B. vulgatus ATCC 8482 and B. vulgatus PC510 that displayed 32 
significant sequence similarity to an NF-κB immunomodulatory regulon previously identified 33 
on a CD-derived metagenomic fosmid clone.  Interestingly, the AB  export system was 34 
specifically enriched in CD subjects suggesting that it may be important for colonization and 35 
persistence in the CD gut environment.  Both B. vulgatus ATCC 8482 and PC510 activated 36 
NF-κB in a strain and growth phase specific manner in a HT-29/kb-seap-25 enterocyte like 37 
cell line.  B. vulgatus ATCC 8482 also activated NF-κB in Caco-2-NF-κBluc enterocyte like 38 
and LS174T-NF-κBluc goblet cell like cell lines and induced NF-κB-p65 subunit nuclear 39 
translocation and IL-6, IL-8, CXCL-10 and MCP-1 gene expression.  Despite this, NF-κB 40 
activation was not coincident with maximal expression of the ABC exporter or lipoprotein in 41 
B. vulgatus PC510 suggesting that the regulon may be necessary but not sufficient for the 42 
immunomodulatory effects. 43 
 44 
Introduction 45 
Inflammatory Bowel Disease (IBD) including the two major disease subtypes ulcerative 46 
colitis (UC) and Crohn’s disease (CD) are characterized by episodic and disabling 47 
inflammation of the gastrointestinal tract.  Although the etiology of IBD is still undefined, the 48 
gut microbiota are now widely believed to contribute to the initiation and recurrence of the 49 
disease [1].  For instance, germ free animal models of IBD do not develop disease until 50 
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colonized by gut bacteria [2, 3].  Second, healthy mice develop colitis following fecal transfer 51 
from colitogenic mice, revealing that disease is transmissible via the microbiota [4].  Third, 52 
antibiotic treatment can be therapeutic in both humans and animal models of IBD [5-7] and 53 
some studies report that fecal transfers can successfully treat UC and CD in human subjects 54 
[8, 9].  Taken together these studies suggest that the gut microbiota is a key driver of IBD 55 
however the identity of the bacteria and/or bacterial factors underpinning active disease 56 
remains largely unknown. 57 
 58 
Cross sectional studies have revealed that the gut microbiota profile differs between healthy 59 
and new onset IBD subjects [10-12] and that the gut microbiota undergoes dramatic structural 60 
alterations that are coincident with the onset of disease [13-15].  However, it is increasingly 61 
accepted that not all gut microbiota population shifts contribute to disease pathogenesis and 62 
that commensal bacteria vary significantly in their ability to initiate and sustain gut 63 
inflammation.  Bacteroides vulgatus is one of the most abundant bacteria in the human gut 64 
where it is widely considered to be a pathobiont – a symbiont that is capable of causing 65 
pathology in response to host and/or environmental triggers.  Consistent with this, recent 66 
research has revealed that B. vulgatus is solely responsible for driving small intestinal injury 67 
in specific pathogen free (SPF) mice lacking the CD relevant intracellular bacterial sensor 68 
nod2 [7].  Similarly, strains of B. vulgatus or Bacteroides thetaiotaomicron induce severe 69 
colitis in SPF mice bearing genetic susceptibilities for host immunity (IL10 and SMAD3 70 
pathways) or gut barrier function (core 1-derived O-glycan biosynthesis) that are relevant to 71 
human CD and UC, but interestingly, do not cause disease in mice not bearing these 72 
susceptibilities [5, 16]. 73 
 74 
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B. vulgatus is characterized by important intraspecies variations with individual isolates 75 
differing in their ability to induce [5, 17] or protect against inflammation [18-20] in animal 76 
models of IBD.  Notably, B. vulgatus is capable of invading colonic epithelial cells [21] and 77 
inducing pro-inflammatory cytokines [17, 21, 22], and tissue adherent strains are enriched in 78 
UC subjects [23] further suggesting a role for this bacterium in the pathogenesis of IBD.  We 79 
recently described a CD-derived metagenomic fosmid clone encoding a putative ATP 80 
Binding Cassette (ABC) exporter and lipoprotein that activates the NF-kappa B (NF-κB) 81 
signalling pathway in a HT-29 gut epithelial enterocyte like cell line [24].  The NF-κB 82 
pathway is central to the pathogenesis of IBD and is widely targeted in an effort to decrease 83 
the frequency and severity of inflammatory episodes, and prevent progression of bowel 84 
damage [25].  In this study, we show that the ABC exporter and lipoprotein are highly 85 
conserved in B. vulgatus and specifically enriched in CD subjects.  Interestingly, B. vulgatus 86 
strains ATCC8482 and PC510 activate NF-κB signaling in a strain specific and growth-phase 87 
dependent manner suggesting that a switch to an inflammogenic state may be part of the 88 
growth-related stress responses of the bacterium. 89 
 90 
Materials and Methods 91 
Genomic analyses of B. vulgatus.  B. vulgatus isolates were identified in the National Centre 92 
for Biotechnology Information (NCBI; www.ncbi.nlm.nih.gov) and Joint Genome Institute 93 
Integrated Microbial Genomes & Microbiomes (IMG/M, https://img.jgi.doe.gov/cgi-94 
bin/mer/main.cgi) databases.  The publicly available genome sequences of B. vulgatus were 95 
downloaded from the National Centre for Biotechnology Information (NCBI; 96 
www.ncbi.nlm.nih.gov) database.  The genome sequences of B. vulgatus ATCC 8482 (NCBI 97 
accession number: NC_009614), B. vulgatus PC510 (NCBI accession number: 98 
NZ_ADKO00000000), B. vulgatus CL09T03C04 (NCBI accession number: 99 
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NZ_AGXZ00000000), B. vulgatus 3775 SR(B) 19 (NCBI accession number: 100 
NZ_JNHJ00000000), B. vulgatus 3775 SL(B) 10 (iv) (NCBI accession number: 101 
NZ_JNHI00000000), B. vulgatus 3975 RP4 (NCBI accession number: NZ_JNHM00000000), 102 
B. vulgatus dnLKV7 (NCBI accession number: NZ_ASSN00000000), B. vulgatus 103 
2789STDY5834842 (NCBI accession number: NZ_CYZI00000000), B. vulgatus 104 
2789STDY5834897 (NCBI accession number: NZ_CZAN00000000), B. vulgatus 105 
2789STDY5834944 (NCBI accession number: NZ_CZBK00000000), Bacteroides sp. 106 
3_1_40A (NCBI accession number: NZ_ACRT00000000), Bacteroides sp. 4_3_47FAA 107 
(NCBI accession number: ACDR02000000), B. vulgatus mpk (NCBI accession number: 108 
NZ_CP013020) and B. vulgatus NLAE-zl-G202 (NCBI accession number: 109 
NZ_FOBA00000000) were downloaded from the NCBI.  The extent of gene synteny in the 110 
genomic regions encoding the ABC export system and lipoprotein was assessed using Mauve 111 
[26] with genome sequences comprised of multiple contigs first aligned against the reference 112 
B. vulgatus ATCC 8482 genome sequence using the Mauve Move Contigs function. 113 
 114 
Abundance of B. vulgatus genes in metagenomes.  Metagenomic sequence and gene 115 
abundance data was downloaded from the Integrated Gene Catalogue (IGC) database, ([27], 116 
http://meta.genomics.cn/metagene/meta/dataTools).  B. vulgatus PC510 coding determining 117 
sequences (CDS) were compared to IGC database using BLAST [28].  The abundance of B. 118 
vulgatus affiliated bacteria in the metagenomic datasets was assessed using the hsp60 119 
housekeeping gene [29].  The B. vulgatus gene counts for hsp60, the ABC export system and 120 
lipoprotein was assessed similarly with the best BLAST hits covering ≥ 90% of the query 121 
nucleotide sequence and having ≥ 98% sequence identity selected for further analysis and 122 
then used as a proxy to determine the respective gene counts in the 141 metagenomes.  Raw 123 
gene counts were divided by the total metagenomic gene read count and then multiplied by 124 
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the total gene count of the smallest metagenome.  Normalized gene read count was then log2 125 
transformed and the counts between Healthy (H, n=59), CD (n=13) and UC (n=69) were 126 
compared between groups using a Wilcoxon test based on the underlying assumption that the 127 
log2 gene counts were not normally distributed.  The p-values were adjusted for multiple 128 
testing using the “false discovery rate” method with padj≤0.05 considered significant. 129 
 130 
Culture and growth experiments.  B. vulgatus ATCC8482 [30] and PC510 [31] were 131 
cultured in Brain Heart Infusion (BHI, Difco™) broth supplemented with 10 mg.L-1 of 132 
haemin, or LYHBHI medium [32], and each medium was buffered with mineral solutions 2 133 
and 3 [33], under anaerobic (95% CO2:5% H2 headspace gasses) conditions.  Bacterial 134 
cultures were routinely manipulated within a Coy vinyl anaerobic chamber with an oxygen 135 
free carbon dioxide/hydrogen (95% CO2:5% H2) atmosphere.  Bacterial growth was 136 
measured by spectrophotometry (OD600nm) using a SPECTRONIC 20D+ Spectrophotometer 137 
(ThermoFisher, Sydney). 138 
 139 
Measurement of B. vulgatus immunomodulatory activities.  The immunomodulatory 140 
potential of the B. vulgatus culture extracts was assessed using the HT-29/kb-seap-25 NF-κB 141 
enterocyte like reporter cell line [24].  Briefly, the HT-29/kb-seap-25 cell line is stably 142 
transfected with a secreted alkaline phosphatase (SEAP) reporter gene under the control of 143 
NF-κB binding elements and it also expresses a subset of TLRs (e.g. TLR3, TLR4 and 144 
TLR5) that are functionally responsive to their cognate ligands [24, 34].  We examined the 145 
immunomodulatory potential of the B. vulgatus strains following growth in LYHBHI 146 
medium.  Briefly, three independent LYHBHI broth cultures were established from 147 
individual colonies of B. vulgatus ATCC8482 or PC510 (n=3 independent biological 148 
replicates per strain) and after overnight growth as described above, each individual culture 149 
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was used to inoculate 5 tubes of LYHBHI broth (n=15, consisting of n=3 independent 150 
biological replicates per strain with n=5 technical replicate for each biological replicate).  The 151 
OD600nm of these cultures was monitored longitudinally and a single tube from each 152 
independent series was sacrificed at early exponential, mid-exponential, early stationary and 153 
late stationary phase of growth.  Cell free culture supernatant was prepared by centrifugation 154 
at 16,000g for 5 minutes and the supernatant fraction was then UV sterilized, filtered through 155 
a 0.2 µm filter and stored at -80oC. 156 
 157 
A 96-well microtiter plate was seeded with 50,000 cells per well and cultured for 24 hours.  158 
Cell free culture bacterial supernatants were added to the cultured cells (10% v/v) and the 159 
mixtures were incubated for a further 24 hours at 37oC.  The amount of secreted SEAP 160 
activity was quantified by in situ spectrophotometry (OD655nm) with the QUANTI-Blue™ 161 
reagent, as directed by the manufacturer (Invivogen™) and average SEAP activity was 162 
calculated from the three independent biological replicates.  The activation of NF-κB by 163 
either un-inoculated LYHBHI bacterial medium and by the NF-κB activator TNFα was also 164 
assessed.  Statistically significant increases in NF-κB activation were identified using a t-test 165 
and accounting for sample variance with a p<0.05 considered to be significant. 166 
 167 
We also assessed B. vulgatus ATCC 8482 immunomodulatory activity using our Caco-2-NF-168 
kBluc enterocyte like and LS174T-NF-kBluc goblet cell like reporter cell lines.  Briefly, 169 
Caco-2 and LS174T cells were treated with transduction medium (DMEM supplemented 170 
with 10% v/v Foetal Bovine Serum and 1% v/v GlutamaxTM (Gibco) supplemented with 171 
6µg.ml-1 polybrene) and 2 x 104 colony forming units of NF-κB Firefly Luciferase reporter 172 
lentivirus (Cellomics Technology), and centrifuged at 1200 g for 90 min at 32°C.  The 173 
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transduction medium was replaced after 24 hours with complete growth medium and 174 
transduced cells were recovered following puromycin selection (2.5 µg.ml-1) for 48 hours. 175 
 176 
For the Caco-2-NF-kBluc and LS174T-NF-kBluc immunomodulatory assays, B. vulgatus 177 
ATCC 8482 culture supernatants were prepared essentially as described above except that 178 
two independent biological experiments were performed.  Next, 96-well microtiter plates 179 
were seeded with 20,000 Caco-2-NF-kBluc or LS174T-NF-kBluc reporter cells per well in 180 
complete medium (DMEM supplemented with 1% v/v GlutamaxTM (Gibco), and 5% or 10% 181 
v/v Foetal Bovine Serum respectively) and cultured for 24 hours.  Then, cell free bacterial 182 
supernatants (10% v/v in complete media) was added to the cultured cells and incubated for 6 183 
hours at 37°C.  The activation of NF-κB was assessed using the PierceTM Firefly Luc One-184 
Step Glow Assay Kit (ThermoFisher Scientific) according to the manufacturer’s instructions. 185 
 186 
Nuclear translocation immunofluorescence assays.  A 12 well-plate was seeded with 187 
20,000 Caco-2 cells per well and cultured overnight at 37°C.  Cell-free late stationary culture 188 
bacterial supernatant (10% v/v) was added to the cultured cells and incubated for 1 hour.  189 
Then, the cells were fixed with 4% paraformaldehyde for 15 minutes and permeabilised using 190 
0.1% Triton X-100 for 5 minutes.  Cells were labelled with mouse anti-NF-κB p65 antibody 191 
(Cell Signaling Technology Inc.) for 1 hour, followed by Alexa Fluor 488 anti-mouse 192 
secondary antibody.  The cells were counterstained with 4′,6-diamidino-2-phenylindole and 193 
visualized with an Olympus Confocal Microscope at 60 x magnification. 194 
 195 
Quantitative reverse transcriptase PCR (qRT-PCR) assays.  Samples of the early 196 
exponential, mid-exponential, early stationary and late stationary growth cultures were also 197 
used for RNA extraction and measurement of the expression of the B. vulgatus PC510 198 
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CUU_1434 (lipoproteinBv510) and CUU_3451 (permeaseBv510) and the B. vulgatus ATCC8482 199 
BVU_2810 (lipoproteinBv8482) and BVU_3172 (permeaseBv8482) by qRT-PCR.  Primers 200 
targeting both lipoproteinBv510 and lipoproteinBv8482 (Pf 5′ CTAATAGTAACTATGTGATTG; 201 
Pr 5′ CTGTCTTTGGTTGCAGTTTCC), permeaseBv510 and permeaseBv8482 (Pf 5′ 202 
GCCTGGCGCTTCTTAATGCG; Pr 5′ TACGCTATGTGCATCCACCG) and total bacteria 203 
[35] were used for relative quantitation using the Q-gene software application [36].  Total 204 
RNA was recovered from the cell pellets using the QIAGEN RNeasey Mini Kit, except that 205 
the cells were lysed with acid washed beads using a BioSpec Mini-Beadbeater-16 206 
Homogenizer at maximum speed for 1 minute; followed by on-column DNase digestion as 207 
recommended by the manufacturers.  The presence of any residual DNA was assessed by 208 
PCR, using primers that target the 16S rRNA gene (27F and 1492R, [37]) and once 209 
confirmed to be DNA free, RNA quality, quantity and integrity was assessed using an Agilent 210 
2100 Bioanalyzer.  Next, cDNA was produced with the SuperScript® III Double-Strand 211 
cDNA Synthesis Kit (Life Technologies™).  Real time PCR analysis was carried out using 212 
SYBR Green Master Mix (Applied Biosystems) and an ABI Prism 7700 (Applied 213 
Biosystems).  Gene expression of the lipoprotein/permease was expressed as the ratio of 214 
lipoprotein/permease gene copy number (GCN) per 16S rRNA GCN. 215 
 216 
To quantify the effect of B. vulgatus ATCC 8482 late stationary phase culture supernatants 217 
on NF-κB regulated cytokine gene expression a 12-well plate was seeded with 20,000 Caco-2 218 
cells per well and cultured for two weeks to generate a confluent monolayer.  The cells were 219 
then treated with late stationary phase B. vulgatus culture supernatants (10% v/v) for 6 hours 220 
at 37°C.  Total RNA was recovered from the cells using an RNeasy® Mini Kit (QIAGEN) 221 
and cDNA was synthesised using an iScriptTM Reverse Transcription Supermix for RT-qPCR 222 
kit (Bio-Rad), as per the manufacturer’s instructions.  Real time quantitative PCR was carried 223 
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out using SYBR Green Master Mix (Applied Biosystems®) and the primers for IL-6 (Pf 5′ 224 
CGCCTTCGGTCCAGTTG; Pr 5′ ATGCAGGTACAGCGTACAGT), IL-8 (Pf 5′ 225 
ACTCCAAACCTTTCCACCC; Pr 5′ CCCTCTTCAAAAACTTCTCCAC), CXCL10 (Pf 5′ 226 
AGCAGAGGAACCTCCAGTCT; Pr 5′ TGTGGTCCATCCTTGGAAGC) and MCP-1 (Pf 5′ 227 
AGTCTCTGCCGCCCTTCT; Pr 5′ GTGACTGGGGCATTGATTG).  Real-time RT-PCR 228 
threshold values (Ct) were normalised to the GAPDH housekeeping gene (Pf 5′ 229 
TGCACCACCACCTGCTTAGC; Pr 5′ GGCATGGACTGTGGTCATGAG) and used to 230 
calculate the fold change in gene expression relative to unstimulated cells. 231 
 232 
Quantification of short chained fatty acid (SCFA) production.  A 2 ml culture of B. 233 
vulgatus PC510 or ATCC8482 was centrifuged at 15,000 g for 15 minutes and 800 µl of cell 234 
free supernatant was transferred in duplicate to a fresh microfuge tube.  Then 80 µl of an 235 
orthophosphoric acid/internal standard solution (20% meta-phosphoric acid/0·24% 4-methyl 236 
valeric acid) was added and the sample was mixed thoroughly.  The concentrations of acetate, 237 
and propionate were determined as previously described with 4-methyl valerate used as an 238 
internal standard [38].  Succinate concentration was determined by ion exchange HPLC using 239 
a Dionex UltiMate® 3000 fitted with a Dionex Acclaim Organic Acid Analytical Column at 240 
30ºC using a 50 mM NaH2PO4 pH 2.7 mobile phase at 0.6 ml.min-1 for 7 minutes.  The 241 
succinate peak was identified and quantified using the Chromeleon software (Dionex). 242 
 243 
Results 244 
A putative NF-κB immunomodulatory regulon is highly conserved in B. vulgatus.  245 
Lakhdari et al., [24] recently identified a metagenomic fosmid clone (52B7) derived from a 246 
CD subject that exerts NF-κB modulatory activity in an E. coli host.  The cloned DNA from 247 
52B7 is predicted to be derived from a Bacteroides sp., and activity is attributable to a 248 
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permease component of an ABC transport efflux system and a distally encoded lipoprotein.  249 
We identified similar genes in both B. vulgatus ATCC8482 (89% amino acid similarity to 250 
BVU_2810 (lipoproteinBv8482) and 99% amino acid similarity to BVU_3172 (permeaseBv8482) 251 
and a recent fecal isolate recovered from a healthy Australian subject B. vulgatus PC510 252 
(92% amino acid similarity to CUU_1434 (lipoproteinBv510) and 99% amino acid similarity to 253 
CUU_3451 (permeaseBv510)) and confirmed that the ABC export system is highly conserved 254 
in these strains (Fig 1).  Further analysis revealed that the ABC export system is conserved 255 
across the 12 other publicly available genome sequences of B. vulgatus isolates recovered 256 
from the human (B. vulgatus CL09T03C04, B. vulgatus 3775 SR(B) 19, B. vulgatus 3775 257 
SL(B) 10(iv), B. vulgatus 3975 RP4, B. vulgatus dnLKV7, B. vulgatus 2789STDY5834842, 258 
B. vulgatus 2789STDY5834897, B. vulgatus 2789STDY5834944, Bacteroides sp. 3_1_40A, 259 
Bacteroides sp. 4_3_47FAA), mouse (B. vulgatus mpk) and goat (B. vulgatus NLAE-zl-260 
G202) gut.  The permeaseBv510 is conserved in closely related Bacteroides spp. (e.g. 261 
Bacteroides dorei CL02T00C15 (97% amino acid similarity to permeaseBv510) and 262 
Bacteroides massiliensis dnLKV3 (86% amino acid similarity to permeaseBv510) and more 263 
distantly related Bacteroides spp. (e.g. Bacteroides fragilis str. 3725 D9 ii (63% amino acid 264 
similarity to permeaseBv510), Bacteroides uniformis 3978 T3 i (53% amino acid similarity to 265 
permeaseBv510)).  As expected, these strains encode ABC export systems although these are 266 
characterized by variations in gene organization suggesting that they may fulfil different 267 
functional roles (Fig 1).  In contrast, the lipoprotein is less highly conserved in B. vulgatus 268 
strains (n=9 of 14 publicly available B. vulgatus isolate genomes) and is also found in select 269 
B. dorei strains but not more distantly related Bacteroides spp. 270 
 271 
The ABC export system is enriched in CD metagenomes.  Next, we determined the 272 
abundance of B. vulgatus affiliated bacteria and the ABC export system in H, CD and UC 273 
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subjects using the IGC database.  The abundance of B. vulgatus affiliated bacteria was 274 
comparable in H, CD and UC metagenomes as assessed using hsp60.  In contrast, except for 275 
CUU_3451 (putative permease), the genes encoding the putative ABC export system 276 
(CUU_3446 to CUU_3455) were significantly enriched in CD as compared to H 277 
metagenomes (Fig 2, padj≤0.05).  Notably, these genes were also more abundant in CD as 278 
compared to UC metagenomes (padj≤0.05).  Finally, the abundance of the lipoprotein 279 
(CUU_1434) was relatively low and similar in all the metagenomes analyzed (Fig 2, 280 
padj≥0.05). 281 
 282 
B. vulgatus exhibits growth-phase dependent NF-κB immunomodulatory activity.  The 283 
NF-κB modulatory activity of 52B7 is primarily associated with the supernatant fraction with 284 
only weak activity associated with the cell lysate fraction [24].  Based on this observation we 285 
assessed the ability of B. vulgatus ATCC 8482 and B. vulgatus PC510 culture supernatants to 286 
modulate activation of NF-κB using the HT-29/kb-seap-25 reporter cell line [24].  Analysis 287 
of culture supernatants harvested from early exponential, mid-exponential, early stationary or 288 
late stationary growth phase revealed that both strains are capable of modulating NF-κB 289 
activation but that the modulatory effect is characterized by growth-phase dependent 290 
intraspecies variations (Fig 3A).  Both strains exhibited immunomodulatory activity in 291 
stationary phase and in particular, the activity of B. vulgatus PC510 at early stationary phase 292 
was significantly higher than that of the LYHBHI medium or supernatant harvested from 293 
early exponential, mid-exponential or late stationary phase (p<0.0001) whereas the activity of 294 
B. vulgatus ATCC 8482 at late stationary phase was significantly higher than that of the 295 
LYHBHI medium or supernatant harvested from any of the preceding time points (Fig 3A, 296 
p<0.0001). 297 
 298 
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We further explored these findings using B. vulgatus ATCC 8482 and our Caco-2-NF-κBluc 299 
and LS174T-NF-κBluc reporter cell lines.  As expected, only late stationary phase culture 300 
supernatants activated NF-κB in Caco-2-NF-κBluc (Figure 3B, p<0.01) and LS174T-NF-301 
κBluc (Figure 3C, p<0.05).  The extent of activation was modest using the LS174T cell line 302 
suggesting it has a higher threshold for activation than the HT-29 and Caco-2 cell lines 303 
possibly due to the higher level of mucin production.  Consistent with this, the addition of 304 
20% v/v culture supernatant from late stationary phase cultures resulted in significant 305 
increase in NF-κB activation in the LS174T-NF-κBluc cell line (Figure 3C, p<0.0001). 306 
 307 
B. vulgatus ATCC 8482 late stationary phase culture supernatant induces NF-κB-p65 308 
subunit nuclear translocation and cytokine expression.  We next examined the ability of 309 
B. vulgatus ATCC 8482 late stationary phase culture supernatant to induce NF-κB-p65 310 
subunit nuclear translocation.  As expected, IL-1β and B. vulgatus late stationary phase 311 
culture supernatant but not sterile culture medium resulted in NF-κB-p65 subunit nuclear 312 
translocation (Fig 4A).  Consistent with this B. vulgatus late stationary phase culture 313 
supernatant induced expression of the NF-κB regulated cytokines IL-6, IL-8, CXCL-10 and 314 
MCP-1 (Fig 4B, p<0.05). 315 
 316 
The B. vulgatus permease and lipoprotein are maximally expressed in late stationary 317 
phase.  We next examined the expression of the permease and lipoprotein genes by qRT-318 
PCR using matched B. vulgatus cells harvested from early exponential, mid-exponential, 319 
early stationary or late stationary phase cultures.  Our analyses revealed that there was low 320 
level expression of the B. vulgatus ATCC8482 permeaseBv8482 and lipoproteinBv8482 in early 321 
exponential, mid-exponential and early stationary phase followed by a significant increase in 322 
expression from early to late stationary phase (Fig 5, p<0.05) which coincided with NF-κB 323 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
14 
 
modulatory activity.  The B. vulgatus PC510 permeaseBv510 was expressed at all-time points 324 
with a significant increase in expression occurring from early to late stationary phase (Fig 5, 325 
p<0.05).  This was also associated with a gradual increase in the expression of the 326 
lipoproteinBv510 with a similar significant increase in expression occurring from early to late 327 
stationary phase (Fig 5, p<0.05) although this was not coincident with NF-κB modulatory 328 
activity. 329 
 330 
B. vulgatus PC510 activates NF-κB independently of SCFA production.  B. vulgatus 331 
produces several short chain fatty acids (SCFA) that have previously been shown to modulate 332 
NF-κB activation [34].  Both B. vulgatus ATCC 8482 and B. vulgatus PC510 produced 333 
acetate, propionate, and succinate when grown in LYHBHI and there was a gradual 334 
accumulation of these SCFAs up to a maximum at late stationary phase (Table 1).  However, 335 
as the culture supernatants are diluted approximately 10-fold for the immunomodulatory 336 
assays the concentrations of acetate and propionate are below the threshold necessary to 337 
induce NF-κB activation in HT-29 cells (≥6mM for acetate, ≥2mM for propionate [34]) at 338 
all-time points.  In contrast, the concentration of succinate in late stationary phase is above 339 
the threshold necessary to induce NF-κB activation (≥6mM succinate [34]) although this was 340 
not coincident with NF-κB activation by B. vulgatus PC510 suggesting that the effect is 341 
mediated via a SCFA independent process. 342 
 343 
Discussion 344 
B. vulgatus is one of the most abundant and prevalent bacteria in the human gut [39-44] 345 
where it is considered to be a member of the healthy human core gut microbiota [45, 46].  346 
While there have been contradictory reports on its relative abundance in CD (e.g. [47, 48]) 347 
and UC subjects (e.g. [11, 49] it appears that B. vulgatus is also capable of colonizing and 348 
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persisting in the dysbiotic IBD gut environment.  To better understand this dichotomy, we 349 
examined the available B. vulgatus genome sequences and identified a putative regulon, 350 
comprised of an ABC export system and lipoprotein, which is similar to an 351 
immunomodulatory regulon previously identified on a CD derived metagenomic fosmid 352 
clone.  Furthermore, we determined that the ability of B. vulgatus to modulate NF-κB is 353 
strain and growth phase dependent suggesting that this capability may be regulated in 354 
response to environmental stressors affecting bacterial growth. 355 
 356 
We previously demonstrated that spent culture supernatant prepared from an E. coli host 357 
carrying 52B7 activated NF-κB in a gut epithelial cell line which is consistent with the 358 
putative efflux function assigned to the ABC transport system [24].  Similarly, to fosmid 359 
52B7 we detected NF-κB modulatory activity in spent culture supernatant prepared from two 360 
independent strains of B. vulgatus.  The extent of activation was less than previously reported 361 
for E. coli carrying 52B7 although this might be related to the heterologous genetic 362 
background of this host [24].  Activation of NF-κB was growth phase dependent and 363 
interestingly the immunomodulatory activity of B. vulgatus PC510 was not coincident with 364 
the maximum expression of the permease and lipoprotein, or with the production of several 365 
SCFA known to affect NF-κB activity, suggesting that these factors may be necessary but not 366 
sufficient for immunomodulatory activity.  For instance, B. vulgatus ATCC 8482 also 367 
produces an N-acyl-amide termed commendamide that activates NF-κB via a G-protein-368 
coupled receptor termed G2A (GPR132) that has been implicated in autoimmunity and 369 
atherosclerosis [50].  While we observed a high degree of concordance between the 370 
individual cell lines it is notable that previous studies reported that HT-29 cells were 371 
unresponsive to B. vulgatus stimulation [34, 51].  However, this may not be surprising 372 
considering that our results suggest that this activity is strain dependent and tightly associated 373 
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with cell growth.  Critically, activation by B. vulgatus PC510 was detectable in early but not 374 
late stationary phase cultures suggesting that NF-κB modulation was likely due to secretion 375 
of a specific factor and not to the general release of microbiota-associated molecular patterns 376 
into the supernatant by stationary phase cultures. 377 
 378 
It is well recognized that several gut pathogens initiate an inflammatory as it confers them 379 
with a competitive advantage in the gut environment.  It remains to be determined whether 380 
specific B. vulgatus strains behave in a similar manner however in addition to a potential 381 
pathogenic role B. vulgatus may also activate NF-κB to establish a tolerogenic relationship 382 
with the host.  For instance, a B. vulgatus strain isolated from a guinea pig with carrageenan 383 
induced colitis activated NF-κB in intestinal epithelial cells in vitro and in vivo [52, 53] 384 
however concomitant induction of TGF-β1 production by lamina propria mononuclear cells 385 
inhibited NF-κB recruitment to the promoter of the pro-inflammatory cytokine IL-6 in the 386 
intestinal epithelial cells [53].  Similarly, B. vulgatus mpk but not E. coli was able to induce a 387 
semi-mature lamina propria dendritic cell phenotype, which may prevent subsequent T-cell 388 
polarization, by triggering IL-6 secretion in the absence of pro-inflammatory cytokines such 389 
as IL-12 or TNFα [54].  IBD is characterized by a loss of tolerance to the gut microbiota and 390 
B. vulgatus may induce both pro and anti-inflammatory pathways in vivo to maintain a 391 
tolerogenic relationship with the host.  It remains to be seen whether this capacity is 392 
characterized by intraspecies variations and how it might influence IBD risk. 393 
 394 
The ability of individual bacterial strains to persist in the gut is supported by their capacity to 395 
rapidly respond and adjust their growth rate to changed environmental conditions.  For B. 396 
vulgatus these adaptations may also be associated with effects on gene expression that affect 397 
its interaction(s) with the host and the inflammatory responses leading to IBD.  Consistent 398 
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with this Sato et al., [23] revealed that the human gut is colonized by multiple strains of B. 399 
vulgatus and that tissue adherent strains are enriched in UC subjects.  Furthermore, Setoyama 400 
et al., [55] previously demonstrated that B. vulgatus strains vary in their ability to drive 401 
colitis.  Both CD and UC are characterized by a high rate of discordance amongst 402 
monozygotic twins (>60% for CD and >80% for UC [56]) and it is known that the gut 403 
microbiota of monozygotic twins differs at the strain level [57].  This raises the intriguing 404 
possibility that intraspecies variations in the strains colonizing healthy and IBD siblings could 405 
influence disease risk. 406 
 407 
Interestingly, while our data suggests that the ABC export system may not be sufficient for 408 
NF-κB activation these genes are more abundant in CD associated metagenomes suggesting 409 
that they are required for B. vulgatus to successfully colonize and persist in this gut 410 
environment.  Unfortunately, B. vulgatus is reported to be recalcitrant to genetic 411 
characterization [58, 59] however a new approach termed metaparental mating [60] may 412 
provide new opportunities to recover genetically tractable isolates thus enabling the 413 
importance of the ABC export system for gut colonization to be assessed by reverse or 414 
forward genetic methods.  The genome sequences of B. vulgatus ATCC8482, PC510 and 415 
mpk have been published [30, 31, 61], the sequences for several other human and animal 416 
derived strains are available in the public databases and a further three genomes have been 417 
sequenced but not yet publicly released (B. vulgatus RJ2H1 (IMG Submission ID: 418 
2510065017), B. vulgatus RJ2L3 (IMG Submission ID: 2510065018) and B. vulgatus 274-419 
1D4 (IMG Genome ID: 2503754051)).  Taken together, we anticipate that an integrated 420 
approach combining functional and genomic dissections will provide new insights into the 421 
gene repertoire necessary to support gut colonization and persistence, and influence host 422 
health. 423 
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 424 
Conclusions 425 
The immunomodulatory capacity of B. vulgatus is characterized by important intraspecies 426 
variations although whether there is a “switch” that transforms the bacterium into a 427 
pathogenic state remains to be determined.  A deeper understanding of the intraspecies 428 
variations and triggers underpinning this switch may provide new insights into the 429 
pathogenesis of inflammatory bowel disease and enable a more sensitive diagnosis and/or 430 
management of disease. 431 
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 637 
Fig 1:  Organization of the genes encoding the putative ABC export system and 638 
lipoprotein from fosmid 52B7 and Bacteroides spp.  The locations of the transposon 639 
insertions that abrogate NF-κB activation in fosmid 52B7 are indicated (closed inverted 640 
triangles).  The genes encoding the B. vulgatus PC510 ABC export system (CUU_3446 – 641 
CUU_3455) are indicated.  We also identified several genes (indicated as putative proteins) 642 
that appear to contain premature translational stop codons in the putative ABC transport 643 
efflux system of 52B7.  644 
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 645 
 646 
Fig 2: Abundance of B. vulgatus PC510 ABC export system in H, CD and UC subjects.  647 
Boxplot depicting the log2 transformed metagenomic read count of hsp60, and the genes 648 
encoding the ABC export system and lipoprotein in healthy (H), Crohn’s disease (CD) and 649 
ulcerative colitis (UC) fecal metagenomes.  * padj-value ≤0.05. 650 
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 653 
 654 
 655 
 656 
 657 
 658 
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 660 
 661 
 662 
 663 
 664 
Fig 3A:  B. vulgatus mediated NF-κB modulation is characterized by intraspecies variations and growth phase dependency.  The effects 665 
of the culture supernatants on NF-κB activation in the HT-29/kb-seap-25 cell line were measured by quantification of SEAP reporter gene 666 
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activity using the QUANTI-Blue™ reagent and average SEAP activity was calculated from three independent experiments.  NF-κB reporter 667 
gene activation (NF-κB activity (OD655nm)) is expressed as the optical density at 655 nm (OD655nm) as assessed following stimulation for 24 668 
hours.  Baseline activation of the reporter gene was assessed using un-inoculated bacterial culture medium (LYHBHI) and B. vulgatus PC510 669 
(ES) and B. vulgatus ATCC8482 late stationary (LS) supernatants that exhibit significantly higher activity compared to the un-inoculated 670 
LYHBHI medium and other experimental time points (early exponential (EX), mid-exponential (MX), early stationary (ES)) are indicated 671 
(p<0.001).  B. The effects of the culture supernatants on NF-κB activation in the Caco-2-NF-κBluc reporter cell line were measured using 672 
luciferase assay.  Average NF-κB activation was accessed following 6 hours stimulation and baseline activation of the reporter gene was 673 
assessed using un-inoculated LYHBHI bacterial culture medium.  B. vulgatus ATCC8482 late stationary (LS) culture supernatants exhibit 674 
significantly higher activity compared to the un-inoculated LYBHI medium on the Caco-2 reporter cell line (p<0.05).  C.  B. vulgatus 675 
ATCC8482 late stationary (LS) culture supernatants significantly increase NF-κB activation on LS174T-NF-Bluc reporter cell line in dose 676 
response manner (10% and 20% respectively) (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001). 677 
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 691 
 692 
Fig 4A.  B. vulgatus ATCC8482 late stationary phase culture supernatant induces NF-κB-p65 subunit nuclear translocation.  Caco-2 693 
cells were stimulated with either IL-1β, LYBHI medium or B. vulgatus ATCC 8482 late stationary culture supernatants for 1 hour.  The cell 694 
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nuclei are indicated in blue while the NF-κB-p65 subunit is indicated in green.  The cell nuclei in the central panels are largely black for 695 
unstimulated Caco-2 cells and cells stimulated with LYHBHI indicating little NF-κB-p65 nuclear translocation.  In contrast, IL-1β and B. 696 
vulgatus LS culture supernatant results in NF-κB-p65 nuclear translocation as revealed by green staining of the nuclei.  Scale bars represents 697 
10µm.  B.  B. vulgatus ATCC8482 late stationary phase culture supernatant induce expression of NF-κB-p65 dependent cytokines.  Caco-2 cell 698 
monolayers were treated with late stationary B. vulgatus ATCC8482 (10% v/v) culture supernatants or LYBHI medium for 6 hours.  The 699 
expression of IL-6, IL-8, CCL2 and CXCL10 was assessed by quantitative RT-PCR.  Data are normalized to GAPDH and presented as fold-700 
change relative to unstimulated cells.  B. vulgatus LS supernatant increased the expression of pro-inflammatory cytokines IL-6 (p<0.05), IL-8 701 
(p<0.001), CCL2 (p<0.05) and CXCL10 (*p<0.05, ***p<0.001). 702 
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 703 
Fig 5.  Maximal expression of the B. vulgatus ATCC8482 but not PC510 lipoprotein and 704 
permease genes is coincident with immunomodulatory activity at late stationary phase.  705 
The extent of gene expression (Gene copies/16S rRNA gene copies) is expressed as the ratio 706 
of gene copies of the lipoprotein or permease per copy of the 16S rRNA gene.  There is a 707 
significant increase in gene expression following the transition from ES to LS phase 708 
(p<0.05).  Early exponential (EX), mid-exponential (MX), early stationary (ES) and late 709 
stationary (LS). 710 
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SCFA 
  
Early exponential phase Mid exponential phase Early stationary phase Late stationary phase 
B. vulgatus B. vulgatus B. vulgatus B. vulgatus 
8482 PC510 8482 PC510 8482 PC510 8482 PC510 
AcOH 2.45±0.20 0.52±0.26 1.93±0.08 2.24±0.19* 3.72±0.13* 8.21±0.37* 11.53±0.19* 12.76±0.17* 
Pr 0.22±0.09 0.01±0.01 0.00±0.00 0.00±0.00 0.00±0.00 0.78±0.08* 13.08±0.99* 9.00±0.12* 
Suc 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.38±0.28 55.92±1.53* 167.61±2.34* 80.63±4.68* 
Table 1.  SCFA production (mM) by B. vulgatus ATCC8482 and B. vulgatus PC510 grown in LYHBHI.  *Statistically significant (p<0.05) 711 
change in SCFA concentration compared to the previous timepoint of the same strain.  AcOH – Acetate; Pr – Propionate; Suc – Succinate 712 
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Highlights for Review 
• The pathobiont Bacteroides vulgatus has been implicated in the etiology of both 
Crohn’s disease (CD) and ulcerative colitis although, relatively little is known about 
how its growth and functional activity might drive the host inflammatory response. 
• We identified an ATP Binding Cassette (ABC) export system and lipoprotein in B. 
vulgatus ATCC 8482 and B. vulgatus PC510 that displayed significant sequence 
similarity to an NF-κB immunomodulatory regulon previously identified on a CD-
derived metagenomic fosmid. 
• The ABC export system was specifically enriched in CD subjects suggesting that it may 
be important for colonization and persistence in the CD gut environment.   
• Both B. vulgatus ATCC 8482 and PC510 activated an NF-κB responsive reporter gene 
in gut epithelial enterocyte and goblet cell culture line in a strain and growth phase 
specific manner.  Consistent with this, B. vulgatus ATCC 8482 also induced NF-κB-
p65 subunit nuclear translocation and expression of IL-6, IL-8, CXCL-10 and MCP-1. 
• However, NF-κB reporter gene activation was not coincident with maximal expression 
of the ABC exporter or lipoprotein in B. vulgatus PC510. 
